ArticleHaematologica2017

Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.

Marius Rohde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.